Shaping the future
Contipro is a Czech-based producer of bioactive compounds for the pharmaceutical and cosmetics industries.
These are substances that we also incorporate into our own applications and final products,
especially when it comes to tissue engineering, biomedicine and wound healing.
Shaping the future
Substance with unlimited potential
Strong & stable background
Avoiding bulls in a china shop
Contipro Group s.r.o. and Contipro Biotech s.r.o. were wounded up, leaving Contipro Pharma a.s. as the sole legal successor, which retained its existing registration number and the legal form of a public limited company. The company name was shortened to Contipro a.s. All liabilities and other legal circumstances of all preceding companies continue to exist unchanged and are concentrated at Contipro a.s.
This merger doesn't impair the legal status of any creditors, business partners, employees or any other parties.
By 1st May 2016, we are not the holding anymore. Now we are Contipro, all together.
Notice for creditors and shareholders of the merging companies in czech (PDF)
Download detailed description of the merger in czech (PDF)
Contipro is born
Free market and private entrepreneurship come to Czechoslovakia and all six founders including the current CEO Dr. Velebný start developing biotechnological production in an ordinary blender as a first step towards their vision.
Hyaluronan with pharmaceutical quality
After years of production of nutritional supplements and cosmetic ingredients, Contipro enters pharmaceutical world.
Veterinary medication for joints
Bonharen is our first really successful final product. Nowadays, Bonharen is synonym for „veterinary joint treatment“ in central Europe.
Contipro enters human medicine market
In human pharmaceutical final products, Contipro is specialized in wound healing. Hyiodine becomes one of the most effective products on the market.
Opening new R&D centre
To reach our goals, we decide to build brand new R&D centre. Science is the very soul of Contipro.
Our R&D in numbers
journals every year